Login / Signup

TYRO3: A potential therapeutic target in cancer.

Pei-Ling HsuJonathan JouShaw-Jeng Tsai
Published in: Experimental biology and medicine (Maywood, N.J.) (2019)
Cancer is among the leading causes of death worldwide. In 2016, 8.9 million people are estimated to have died from various forms of cancer. The current treatments, including surgery with chemotherapy and/or radiation therapy, are not effective enough to provide full protection from cancer, which highlights the need for developing novel therapy strategies. In this review, we summarize the molecular biology of a unique member of a subfamily of receptor tyrosine kinase, TYRO3 and discuss the new insights in TYRO3-targeted treatment for cancer therapy.
Keyphrases